NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 116 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,732 | +100.8% | 22,180 | +665.9% | 0.00% | – |
Q1 2023 | $11,816 | -50.2% | 2,896 | -38.8% | 0.00% | – |
Q4 2022 | $23,750 | -49.5% | 4,731 | +77.0% | 0.00% | – |
Q4 2021 | $47,000 | +176.5% | 2,673 | +231.2% | 0.00% | – |
Q3 2021 | $17,000 | -82.7% | 807 | -83.7% | 0.00% | – |
Q2 2021 | $98,000 | -92.0% | 4,947 | -88.3% | 0.00% | – |
Q1 2021 | $1,226,000 | +121.3% | 42,200 | +130.6% | 0.00% | – |
Q4 2020 | $554,000 | +182.7% | 18,300 | +48.8% | 0.00% | – |
Q3 2020 | $196,000 | +3.7% | 12,300 | +28.3% | 0.00% | – |
Q2 2020 | $189,000 | +45.4% | 9,589 | -9.0% | 0.00% | – |
Q1 2020 | $130,000 | -73.6% | 10,534 | -60.5% | 0.00% | – |
Q4 2019 | $492,000 | +287.4% | 26,659 | +192.4% | 0.00% | – |
Q3 2019 | $127,000 | +605.6% | 9,117 | +651.6% | 0.00% | – |
Q2 2019 | $18,000 | – | 1,213 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |